News Industry News Titanium-Nitride-Oxide Bio Active Technology in ACS Patients: Present and Future May 18, 2011
News Industry News A Prospective, Randomised and Multicentre Trial Comparing Titan2 Bio Active Stent (BAS) and Xience V Drug Eluting Stent (DES): The BASE-ACS Trial May 17, 2011
News Daily News LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD Jason Kahn April 21, 2011
News Daily News Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus April 20, 2011
News Daily News Women Less Likely to Receive Evidence-Based Therapies Than Men Jason Kahn March 09, 2011